Found 13 matching trials
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC PHASE1 Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Show More Location
the First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer PHASE2 This is an open-label, single-arm, phase II, multi-center clinical trial. T...
Show More Location
Sun Yat sen University cancer center
Learn More & Join Trial
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) PHASE3 This is a randomized, controlled, multi-center, phase III clinical study to...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial PHASE2 For stage III non-small cell lung cancer (NSCLC), neoadjuvant chemotherapy ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC. PHASE2 This is a Phase 2, prospective, single-arm, open-Label, single-center study...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC PHASE2 This study is a Phase II study to evaluate the clinical efficacy and safety...
Show More Status
Active Not Recruiting
Location
Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial
A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC) PHASE3 The purpose of the study is to compare the efficacy and safety of SYS6010 i...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC PHASE3 This is a randomized, double-blind, placebo-controlled, multi-center, phase...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study) PHASE3 The SCIENCE trial is a multicenter, open-label, randomized, parallel, nonin...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer PHASE2 For extensive-stage small cell lung cancer (SCLC), platinum-chemotherapy (c...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial